Trial participants' rights after authorisation of COVID-19 vaccines.

Dal-Ré, Rafael; Orenstein, Walter; Caplan, Arthur L

Dal-Ré, Rafael; Orenstein, Walter; Caplan, Arthur L.

Dal-Ré R; Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, E-28040 Madrid, Spain. Electronic address: rafael.dalre@quironsalud.es.
Orenstein W; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA; Emory Vaccine Center, Emory University, Atlanta, GA, USA.
Caplan AL; Division of Medical Ethics, Grossman School of Medicine, NYU Langone Medical Center, New York, NY, USA.

Lancet Respir Med ; 9(4): e30-e31, 2021 04.

Article in English | MEDLINE | ID: covidwho-1180135

Subject(s)

COVID-19 Vaccines/administration & dosage; COVID-19/prevention & control; Patient Rights/ethics; Placebos/administration & dosage; Randomized Controlled Trials as Topic/ethics; Double-Blind Method; Humans; Informed Consent; Patient Selection; Practice Guidelines as Topic; Randomized Controlled Trials as Topic/standards

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Placebos / Randomized Controlled Trials as Topic / Patient Rights / COVID-19 Vaccines / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Lancet Respir Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google